Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MUHC announces a Canadian first: the first successful implantation of a long-term mechanical heart as an alternative to transpla

14.12.2006
The MUHC is pleased to announce the first successful Canadian implantation of a new long-term mechanical heart as an alternative to heart transplant. On 23 November 2006, the MUHC Heart Failure team implanted the HeartMate II mechanical heart in 65 year-old Gerard Langevin, of Coteau-du-Lac, Quebec.

The HeartMate II, which may last up to 10 years, is being used as part of a clinical trial at the MUHC. It represents a new generation of mechanical heart and the first real long-term alternative to a heart transplant.

"Although several Heartmate II implantations have been conducted in the US, Mr. Langevin is currently the only person in Canada to be fitted with this new technology and we are proud to announce today that he is going home," says Dr. Renzo Cecere, Director of the Mechanical Assist Program, Surgical Director of the Heart Failure and Heart Transplant Program of the MUHC and the surgeon that conducted the 3 hour operation to implant the HeartMate II.

The Heartmate II is currently part of a clinical trial administrated by the manufacturers Thoratec at selected hospitals in the USA and Canada; as such this device has yet to be approved for use in either country. The MUHC, which has the largest mechanical heart program in Quebec, was chosen to participate because the complex nature of the surgical procedure required an experienced heart failure team and a comprehensive multi-disciplinary program. Only one other Canadian hospital - the Toronto General Hospital - was invited to participate in the study.

"Our patient suffered from severe heart failure after a heart attack in July 2006," says Dr. Nadia Giannetti, Medical Director of the Heart Failure and Heart Transplant Program of MUHC. "Despite all the conventional therapies, his heart remained very weak, and he had become unable to live a normal life." Due to other medical conditions, Mr. Langevin was deemed an unsuitable candidate for transplant. His organs started to fail and he was readmitted to hospital many times. "Previously we would have had little else to offer Mr. Langevin, and his heart would have continued to deteriorate," says Dr. Giannetti. "But because of our access to the HeartMate II, he is now doing very well and can expect to do so for many years to come."

"Before receiving my mechanical heart, I couldn't do anything at all. Even walking a few steps was difficult because I was so weak and my breathing was so bad," says Mr. Langevin. "Now, with this new mechanical heart, I have lots of energy, and my breathing is great even while doing activities."

Similar in size and weight to a standard 'D' sized battery, the Heartmate II is significantly smaller than any previous mechanical heart. The device is internal and operates silently through a cable connecting to the battery. An interesting feature of the Heartmate II is that the device provides a continuous flow of blood, so the patient has no pulse. One of the most important aspects of this new technology is its use as a destination therapy. "This means that rather than acting as a bridge to transplant, the Heartmate II, with its greatly expanded lifespan compared to previous mechanical hearts, can be considered an alternative to a heart transplant," says Dr. Cecere. "Because of the lack of adequate donor hearts for people with end-stage heart failure, there is a great need for alternatives to transplant. Now we finally have an off-the-shelf device that can be implanted immediately as a long-term alternative."

The McGill University Health Centre (MUHC) is a comprehensive academic health institution with an international reputation for excellence in clinical programs, research and teaching. The MUHC is a merger of five teaching hospitals affiliated with the Faculty of Medicine at McGill University--the Montreal Children's, Montreal General, Royal Victoria, and Montreal Neurological Hospitals, as well as the Montreal Chest Institute. Building on the tradition of medical leadership of the founding hospitals, the goal of the MUHC is to provide patient care based on the most advanced knowledge in the health care field, and to contribute to the development of new knowledge.

Ian Popple | MUHC
Further information:
http://www.muhc.ca

More articles from Medical Engineering:

nachricht True to type: From human biopsy to complex gut physiology on a chip
14.02.2018 | Wyss Institute for Biologically Inspired Engineering at Harvard

nachricht The Scanpy software processes huge amounts of single-cell data
12.02.2018 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

Im Focus: Autonomous 3D scanner supports individual manufacturing processes

Let’s say the armrest is broken in your vintage car. As things stand, you would need a lot of luck and persistence to find the right spare part. But in the world of Industrie 4.0 and production with batch sizes of one, you can simply scan the armrest and print it out. This is made possible by the first ever 3D scanner capable of working autonomously and in real time. The autonomous scanning system will be on display at the Hannover Messe Preview on February 6 and at the Hannover Messe proper from April 23 to 27, 2018 (Hall 6, Booth A30).

Part of the charm of vintage cars is that they stopped making them long ago, so it is special when you do see one out on the roads. If something breaks or...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Fingerprints of quantum entanglement

16.02.2018 | Information Technology

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers

16.02.2018 | Health and Medicine

Hubble sees Neptune's mysterious shrinking storm

16.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>